BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19136940)

  • 1. GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986.
    Gupta SK; Mishra R; Kusum S; Spedding M; Meiri KF; Gressens P; Mani S
    Cell Death Differ; 2009 Apr; 16(4):624-37. PubMed ID: 19136940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
    Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P
    Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
    O'Neill MJ; Murray TK; Whalley K; Ward MA; Hicks CA; Woodhouse S; Osborne DJ; Skolnick P
    Eur J Pharmacol; 2004 Feb; 486(2):163-74. PubMed ID: 14975705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and biological effects of chronic S18986, a positive AMPA receptor modulator, during aging.
    Bloss EB; Hunter RG; Waters EM; Munoz C; Bernard K; McEwen BS
    Exp Neurol; 2008 Mar; 210(1):109-17. PubMed ID: 18035355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic drugs become neurotoxic in cortical neurons pre-exposed to brain-derived neurotrophic factor.
    Molinaro G; Battaglia G; Riozzi B; Storto M; Fucile S; Eusebi F; Nicoletti F; Bruno V
    Mol Cell Neurosci; 2008 Feb; 37(2):312-22. PubMed ID: 18055218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons.
    Wu CL; Hwang CS; Yang DI
    Neurotoxicology; 2009 Jul; 30(4):718-26. PubMed ID: 19428112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc.
    Rao VR; Pintchovski SA; Chin J; Peebles CL; Mitra S; Finkbeiner S
    Nat Neurosci; 2006 Jul; 9(7):887-95. PubMed ID: 16732277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia.
    Xapelli S; Bernardino L; Ferreira R; Grade S; Silva AP; Salgado JR; Cavadas C; Grouzmann E; Poulsen FR; Jakobsen B; Oliveira CR; Zimmer J; Malva JO
    Eur J Neurosci; 2008 Apr; 27(8):2089-102. PubMed ID: 18412629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for AMPA receptors in mood disorders.
    Alt A; Nisenbaum ES; Bleakman D; Witkin JM
    Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF increases the number of axotomized rat retinal ganglion cells expressing GAP-43, L1, and TAG-1 mRNA--a supportive role for nitric oxide?
    Klöcker N; Jung M; Stuermer CA; Bähr M
    Neurobiol Dis; 2001 Feb; 8(1):103-13. PubMed ID: 11162244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of glutamate receptor-mediated BDNF mRNA expression in the cerebellum and its defects in stargazer mice.
    Meng H; Gao R; Dai Q; Qiao X
    Neuropharmacology; 2007 Jul; 53(1):81-91. PubMed ID: 17544459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor regulates the expression of D1 dopamine receptors.
    Do T; Kerr B; Kuzhikandathil EV
    J Neurochem; 2007 Jan; 100(2):416-28. PubMed ID: 17116228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge.
    Husson I; Rangon CM; Lelièvre V; Bemelmans AP; Sachs P; Mallet J; Kosofsky BE; Gressens P
    Cereb Cortex; 2005 Mar; 15(3):250-61. PubMed ID: 15269108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
    Bourasset F; Bernard K; Muñoz C; Genissel P; Scherrmann JM
    Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of the aryl hydrocarbon receptor attenuates excitotoxicity and enhances NMDA-induced BDNF expression in cortical neurons.
    Lin CH; Chen CC; Chou CM; Wang CY; Hung CC; Chen JY; Chang HW; Chen YC; Yeh GC; Lee YH
    J Neurochem; 2009 Nov; 111(3):777-89. PubMed ID: 19712055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein.
    Fowler JH; Edgar JM; Pringle A; McLaughlin M; McCulloch J; Griffiths IR; Garbern JY; Nave KA; Dewar D
    J Neurosci Res; 2006 Jul; 84(1):68-77. PubMed ID: 16625661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge.
    Bemelmans AP; Husson I; Jaquet M; Mallet J; Kosofsky BE; Gressens P
    J Neurosci Res; 2006 Jan; 83(1):50-60. PubMed ID: 16299771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of neurite growth with AMPA receptor potentiation.
    Voss OP; Milne S; Sharkey J; O'Neill MJ; McCulloch J
    Neuropharmacology; 2007 Feb; 52(2):590-7. PubMed ID: 17101156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.